Dingping Yang

685 total citations
29 papers, 538 citations indexed

About

Dingping Yang is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Dingping Yang has authored 29 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 8 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Dingping Yang's work include Acute Kidney Injury Research (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal Diseases and Glomerulopathies (3 papers). Dingping Yang is often cited by papers focused on Acute Kidney Injury Research (14 papers), Chronic Kidney Disease and Diabetes (7 papers) and Renal Diseases and Glomerulopathies (3 papers). Dingping Yang collaborates with scholars based in China and United States. Dingping Yang's co-authors include Ruhan Jia, Guohua Ding, Xueyan Yang, Jijia Hu, Jun Feng, Guohua Ding, Jili Zhu, Zhaowei Chen, Zijing Zhu and Jinlei Lv and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of the American Society of Nephrology and Cellular and Molecular Life Sciences.

In The Last Decade

Dingping Yang

24 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingping Yang China 17 229 196 88 72 70 29 538
Xinli Xu China 9 322 1.4× 246 1.3× 54 0.6× 48 0.7× 47 0.7× 12 690
Weiyan Lai China 9 113 0.5× 139 0.7× 79 0.9× 39 0.5× 64 0.9× 15 389
Qunzi Zhang China 12 196 0.9× 135 0.7× 58 0.7× 53 0.7× 12 0.2× 20 488
Xiaogang Du China 16 204 0.9× 245 1.3× 203 2.3× 122 1.7× 17 0.2× 44 791
Fei Fang Canada 11 84 0.4× 240 1.2× 101 1.1× 77 1.1× 18 0.3× 16 649
Mengqing Ma China 13 102 0.4× 271 1.4× 209 2.4× 61 0.8× 52 0.7× 51 656
Sung-Gyu Cho United States 6 271 1.2× 564 2.9× 139 1.6× 45 0.6× 18 0.3× 6 918
Yi Guan China 11 134 0.6× 200 1.0× 111 1.3× 33 0.5× 163 2.3× 20 622
Suyan Duan China 12 209 0.9× 204 1.0× 114 1.3× 25 0.3× 10 0.1× 38 527
Edyta Zbroch Poland 15 176 0.8× 349 1.8× 34 0.4× 55 0.8× 14 0.2× 46 606

Countries citing papers authored by Dingping Yang

Since Specialization
Citations

This map shows the geographic impact of Dingping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingping Yang more than expected).

Fields of papers citing papers by Dingping Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingping Yang. The network helps show where Dingping Yang may publish in the future.

Co-authorship network of co-authors of Dingping Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Dingping Yang. A scholar is included among the top collaborators of Dingping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingping Yang. Dingping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Huang, Jing, et al.. (2025). Mesenchymal cell-derived exosomes and miR-29a-3p mitigate renal fibrosis and vascular rarefaction after renal ischemia reperfusion injury. Stem Cell Research & Therapy. 16(1). 135–135. 5 indexed citations
3.
Mei, Jialin, Bing Zhang, Lei Chen, et al.. (2025). A novel nomogram for predicting mediastinal lymph node metastasis in non-small cell lung cancer: a retrospective analysis. Journal of Thoracic Disease. 17(8). 5803–5815.
4.
Wei, Cong, et al.. (2024). Visual and auditory attention defects in children with intermittent exotropia. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 50(1). 17–17. 2 indexed citations
5.
Yang, Xueyan, et al.. (2023). Ox‐LDL aggravates contrast‐induced injury of renal tubular epithelial cells. Journal of Biochemical and Molecular Toxicology. 37(8). e23379–e23379. 5 indexed citations
6.
Ding, Guohua, et al.. (2023). B‑cell lymphoblastic lymphoma‑associated renal damage: A case report and literature review. Experimental and Therapeutic Medicine. 25(2). 85–85.
7.
Yang, Xueyan, Zhaowei Chen, Dingping Yang, et al.. (2023). STING deletion alleviates podocyte injury through suppressing inflammation by targeting NLRP3 in diabetic kidney disease. Cellular Signalling. 109. 110777–110777. 22 indexed citations
8.
Yang, Xueyan, et al.. (2022). SIRT3 deficiency exacerbates early-stage fibrosis after ischaemia-reperfusion-induced AKI. Cellular Signalling. 93. 110284–110284. 28 indexed citations
9.
Yang, Xueyan, Jun Feng, Wei Liang, et al.. (2021). Roles of SIRT6 in kidney disease: a novel therapeutic target. Cellular and Molecular Life Sciences. 79(1). 53–53. 33 indexed citations
10.
Liu, Chunhua, et al.. (2021). MicroRNA‐214‐5p aggravates sepsis‐related acute kidney injury in mice. Drug Development Research. 83(2). 339–350. 21 indexed citations
12.
Yang, Qian, Jijia Hu, Yingjie Yang, et al.. (2020). Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes. Theranostics. 10(16). 7465–7479. 52 indexed citations
13.
Zhu, Jili, Huiming Wang, & Dingping Yang. (2014). IgA Nephropathy with Pathologic Features of Membranoproliferative Glomerulonephritis following Burn Injury. Case Reports in Nephrology and Dialysis. 4(1). 31–36. 6 indexed citations
14.
Yang, Yifei, et al.. (2014). Role of Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress in Contrast-Induced Renal Tubular Cell Apoptosis. Nephron Experimental Nephrology. 128(1-2). 30–36. 22 indexed citations
15.
Yang, Dingping, et al.. (2013). Role of Intracellular Ca2+and Na+/Ca2+Exchanger in the Pathogenesis of Contrast-Induced Acute Kidney Injury. BioMed Research International. 2013. 1–5. 19 indexed citations
16.
Yang, Dingping, et al.. (2013). Na+/Ca2+ exchange inhibitor, KB-R7943, attenuates contrast-induced acute 
kidney injury. Journal of Nephrology. 26(5). 877–885. 24 indexed citations
17.
Yang, Dingping, et al.. (2013). Selective Inhibition of the Reverse Mode of Na<sup>+</sup>/Ca<sup>2+</sup> Exchanger Attenuates Contrast-Induced Cell Injury. American Journal of Nephrology. 37(3). 264–273. 18 indexed citations
18.
Yang, Dingping, et al.. (2011). Effects of Short- and Long-Term Hypercholesterolemia on Contrast-Induced Acute Kidney Injury. American Journal of Nephrology. 35(1). 80–89. 23 indexed citations
19.
Lv, Jinlei, Ruhan Jia, Dingping Yang, Jili Zhu, & Guohua Ding. (2009). Candesartan attenuates Angiotensin II-induced mesangial cell apoptosis via TLR4/MyD88 pathway. Biochemical and Biophysical Research Communications. 380(1). 81–86. 49 indexed citations
20.
Xiong, Xiaoling, Ruhan Jia, Dingping Yang, & Guohua Ding. (2006). Irbesartan attenuates contrast media-induced NRK-52E cells apoptosis. Pharmacological Research. 54(4). 253–260. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026